CXCL8 and prostate cancer: Higher levels of some TLR4 downstream cytokines (e.g., IL-8) have been observed in prostate cancer tissues compared with control non-tumor tissues (59), suggesting that prostate cells experience persistent elevated inflammation presumably in response to bacterial products such as LPS as well as endogenous TLR4 ligands released from injured cells.